ArcBest (ARCB) “announced that its board of directors has approved an increase in the company’s share repurchase authorization to a total of $125 million.”
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ARCB:
- ArcBest price target lowered to $79 from $83 at Citi
- ArcBest price target lowered to $75 from $78 at BofA
- Cautious Hold Rating for ArcBest Amid Macroeconomic Pressures and Industry Challenges
- ArcBest Reports Q3 2025 Financial Results Amid Challenges
- Trump Trade: $2B of CHIPS Act funds may be reallocated to minerals